• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过服务评估制定临床药师干预静脉血栓栓塞预防措施的经济案例。

Developing an Economic Case of Clinical Pharmacists' Interventions on Venous Thromboembolism Prophylaxis Through Service Evaluation.

作者信息

Lee Eun Hee, Bray Victoria, Horne Robert

机构信息

Department of Pharmacy, University College London, London, England.

Emergency Department, St. George's University Hospitals NHS Foundation Trust, London, England.

出版信息

J Res Pharm Pract. 2017 Apr-Jun;6(2):106-113. doi: 10.4103/jrpp.JRPP_16_160.

DOI:10.4103/jrpp.JRPP_16_160
PMID:28616434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5463545/
Abstract

OBJECTIVE

Venous thromboembolism (VTE) has become a huge health problem as well as a financial burden for the National Health Service. The objective of this study was to characterize current practice of VTE prophylaxis (VTEP) and evaluate the economic impact of clinical pharmacists' interventions (CPIs) on VTEP.

METHODS

A prospective service evaluation was conducted in a medical and surgical ward at a tertiary teaching hospital in London from 23 May to 08 June 2016. Appropriateness of risk assessment (RA) and VTEP and CPIs were categorized and assessed. Based on the results of the service evaluation, a pharmacoeconomic analysis was undertaken to estimate the cost savings by CPIs for inappropriate pharmacological VTEP.

FINDINGS

A total of 203 cases were analyzed. The rates of appropriateness for RA on admission, RA at 24 h and pharmacological VTEP were 58.6%, 39.7%, and 75.4%, respectively. In the medical ward, there was a significant difference of appropriate RAs between on admission and at 24 h (70.3% vs. 23.8%, respectively). Whereas, the rate of appropriate pharmacological VTEP accounted for 75.4% and the rate of appropriate prophylaxis was significantly higher in the medical ward than surgical ward (80.5% vs. 68.2%, = 0.045). Of 50 cases of inappropriate pharmacological prophylaxis, 39 cases (78.0%) were corrected by clinical pharmacists. These CPIs resulted in £1,286.23 cost savings during the study and it was estimated to be £517,522/annum.

CONCLUSION

CPIs had significant positive clinical and economic impacts on VTEP. There is more scope for the improvement of RA at 24 h through CPIs.

摘要

目的

静脉血栓栓塞症(VTE)已成为一个重大的健康问题,同时也给国民医疗服务体系带来了经济负担。本研究的目的是描述当前VTE预防(VTEP)的实践情况,并评估临床药师干预(CPls)对VTEP的经济影响。

方法

2016年5月23日至6月8日,在伦敦一家三级教学医院的内科和外科病房进行了一项前瞻性服务评估。对风险评估(RA)、VTEP和CPls的适宜性进行分类和评估。基于服务评估结果,进行了药物经济学分析,以估计CPls对不适当的药物性VTEP节省的成本。

结果

共分析了203例病例。入院时RA、24小时RA和药物性VTEP的适宜率分别为58.6%、39.7%和75.4%。在内科病房,入院时和24小时时适宜RA存在显著差异(分别为70.3%和23.8%)。而药物性VTEP的适宜率为75.4%,内科病房的适宜预防率显著高于外科病房(80.5%对68.2%,P = 0.045)。在50例不适当的药物预防病例中,39例(78.0%)被临床药师纠正。这些CPls在研究期间节省了1286.23英镑的成本,估计每年节省517522英镑。

结论

CPls对VTEP有显著的积极临床和经济影响。通过CPls在24小时时改善RA有更大的空间。

相似文献

1
Developing an Economic Case of Clinical Pharmacists' Interventions on Venous Thromboembolism Prophylaxis Through Service Evaluation.通过服务评估制定临床药师干预静脉血栓栓塞预防措施的经济案例。
J Res Pharm Pract. 2017 Apr-Jun;6(2):106-113. doi: 10.4103/jrpp.JRPP_16_160.
2
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis.在实施静脉血栓栓塞预防改善项目期间,一项静脉血栓栓塞预防改善项目对住院患者血栓栓塞发生率和出血率的影响。
Mayo Clin Proc Innov Qual Outcomes. 2020 Feb 17;4(2):159-169. doi: 10.1016/j.mayocpiqo.2019.10.006. eCollection 2020 Apr.
3
Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers.降低学术医院网络中医院相关性静脉血栓栓塞的发生率:来自加利福尼亚大学五个医学中心的研究结果。
J Hosp Med. 2016 Dec;11 Suppl 2:S22-S28. doi: 10.1002/jhm.2658.
4
Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.高危手术患者静脉血栓栓塞症医生-药师联合处方的成本效益分析
BMC Health Serv Res. 2018 Oct 1;18(1):749. doi: 10.1186/s12913-018-3557-0.
5
Risk-to-Benefit Ratio of Venous Thromboembolism Prophylaxis for Neurosurgical Procedures at a Quaternary Referral Center.四级转诊中心神经外科手术中静脉血栓栓塞症预防的风险-效益比。
Neurosurgery. 2019 Feb 1;84(2):355-361. doi: 10.1093/neuros/nyy035.
6
Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.住院镰状细胞病和镰状细胞性状患者的静脉血栓栓塞预防
Eur J Haematol. 2022 Sep;109(3):282-288. doi: 10.1111/ejh.13807. Epub 2022 Jun 8.
7
Unintended consequences of a standard admission order set on venous thromboembolism prophylaxis and patient outcomes.标准入院医嘱集对静脉血栓栓塞症预防和患者结局的意外后果。
J Gen Intern Med. 2012 Mar;27(3):318-24. doi: 10.1007/s11606-011-1871-x. Epub 2011 Sep 24.
8
Timing of venous thromboprophylaxis in isolated severe pelvic fracture: Effect on mortality and outcomes.孤立性严重骨盆骨折患者的静脉血栓预防时机:对死亡率和结局的影响。
Injury. 2019 Mar;50(3):697-702. doi: 10.1016/j.injury.2019.02.009. Epub 2019 Feb 14.
9
Venous Thromboembolism Chemoprophylaxis Compliance in the Surgical Intensive Care Unit.外科重症监护病房静脉血栓栓塞症化学预防的依从性。
Am Surg. 2023 Oct;89(10):4050-4054. doi: 10.1177/00031348231175493. Epub 2023 May 14.
10
A Systematic Review of the Risks and Benefits of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury.颅脑创伤患者静脉血栓栓塞症预防的风险与获益的系统评价
Can J Neurol Sci. 2018 Jul;45(4):432-444. doi: 10.1017/cjn.2017.275. Epub 2018 Jun 13.

引用本文的文献

1
Evaluation of the Effect of Management of Drug-Related Problems on Clinical Outcomes of Pulmonary Embolism Outpatients: A Randomized Controlled Trial.药物相关问题管理对肺栓塞门诊患者临床结局的影响评估:一项随机对照试验
J Clin Med. 2025 Feb 12;14(4):1202. doi: 10.3390/jcm14041202.
2
Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.巴西一家三级教学医院神经内科临床药师干预分析。
PLoS One. 2019 Jan 18;14(1):e0210779. doi: 10.1371/journal.pone.0210779. eCollection 2019.

本文引用的文献

1
Clinical and economic evaluation of pharmacists' contribution to patient care on a multi-disciplinary liver transplant team.药剂师对多学科肝移植团队患者护理贡献的临床与经济评估
Int J Clin Pharmacol Ther. 2016 Feb;54(2):102-9. doi: 10.5414/CP202501.
2
Implementation of Pharmaceutical Practice Guidelines by a Project Model Based: Clinical and Economic Impact.基于项目模型实施药学实践指南:临床和经济影响
Medicine (Baltimore). 2015 Oct;94(42):e1744. doi: 10.1097/MD.0000000000001744.
3
Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium.
在比利时,由药剂师主导的干预措施改善了急性病内科患者的静脉血栓栓塞预防情况。
Int J Clin Pharm. 2014 Oct;36(5):1007-13. doi: 10.1007/s11096-014-9988-8. Epub 2014 Aug 3.
4
Implementation of vertical clinical pharmacist service on venous thromboembolism prophylaxis in hospitalized medical patients.在住院内科患者中实施垂直临床药师预防静脉血栓栓塞服务。
Einstein (Sao Paulo). 2014 Jan-Mar;12(1):27-30. doi: 10.1590/s1679-45082014ao2526.
5
Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital.加拿大一家医院药剂师提供的术后护理的临床益处及经济影响。
Int J Pharm Pract. 2014 Jun;22(3):216-22. doi: 10.1111/ijpp.12058. Epub 2013 Aug 18.
6
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
7
Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.住院炎症性肠病患者静脉血栓栓塞症预防的预测因素和安全性。
J Crohns Colitis. 2013 Nov;7(10):e479-85. doi: 10.1016/j.crohns.2013.03.002. Epub 2013 Mar 26.
8
Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.评价感染病科临床药师干预对患者直接药品费用的影响。
Eur J Intern Med. 2013 Apr;24(3):227-33. doi: 10.1016/j.ejim.2012.11.014. Epub 2012 Dec 12.
9
Improving prevention and treatment of venous thromboembolism: clinical trial results.改善静脉血栓栓塞症的预防和治疗:临床试验结果。
J Med Econ. 2012;15(4):611-22. doi: 10.3111/13696998.2012.667026. Epub 2012 Feb 28.
10
Patient education program for venous thromboembolism prevention in hospitalized patients.患者教育计划预防住院患者静脉血栓栓塞症。
Am J Med. 2012 Mar;125(3):258-64. doi: 10.1016/j.amjmed.2011.09.012.